Aster DM Healthcare Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on March 10, 2026
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare held a court-convened meeting of equity shareholders on March 10, 2026, as directed by the NCLT Hyderabad bench, to consider and approve the Scheme of Amalgamation with Quality Care India Limited (Transferor Company). The meeting was chaired by Ms. Sandhya Rani, Advocate (appointed by NCLT), and was attended by 64 members. Ms. Alisha Moopen, Deputy Managing Director, explained the salient features of the scheme and addressed shareholder queries. Remote e-voting took place from March 6 to March 9, 2026, with additional e-voting conducted during the meeting. The meeting concluded at 10:55 AM, and the voting results along with the Scrutinizer's report will be shared with the stock exchanges within prescribed timelines.
This is a procedural update on the NCLT-mandated shareholder approval process for the proposed merger with Quality Care India Limited. Investors should await the formal voting results, which will determine whether the scheme has been approved and whether the merger moves to the next stage of NCLT and other regulatory clearances.